financetom
MRCY
financetom
/
Industrials
/
MRCY
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Mercury Systems, Inc.MRCY
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Mercury Systems, Inc., a technology company, manufactures and sells components, products, modules, and subsystems for aerospace and defense industries in the United States, Europe, and the Asia Pacific.

Its products and solutions are deployed in approximately 300 programs with 25 defense contractors and commercial aviation customers.

The company offers components, including power amplifiers and limiters, switches, oscillators, filters, equalizers, digital and analog converters, chips, monolithic microwave integrated circuits, and memory and storage devices; modules and sub-assemblies, such as embedded processing boards, switched fabrics and boards, digital receivers, multi-chip modules, integrated radio frequency and microwave multi-function assemblies, tuners, and transceivers, as well as graphics and video boards; and integrated subsystems.

It also designs and develops digital radio frequency memory units for various modern electronic warfare applications; radar environment simulation and test systems for defense and intelligence applications; and signals intelligence payloads and EO/IR technologies for small UAV platforms, as well as onboard UAV processor systems for real-time wide area motion imagery.

The company was formerly known as Mercury Computer Systems, Inc. and changed its name to Mercury Systems, Inc. in November 2012.

The company was incorporated in 1981 and is headquartered in Andover, Massachusetts.

Latest News >
Why Avenue Therapeutics (ATXI) Shares Are Getting Hammered
Why Avenue Therapeutics (ATXI) Shares Are Getting Hammered
Apr 24, 2024
Avenue Therapeutics Inc ( ATXI ) shares are trading lower by 28.5% to $0.09 during Wednesday’s session after the company announced a reverse stock split. The company is implementing a 1-for-75 reverse stock split of its common stock, effective April 26. This decision, approved by the company’s Board of Directors and a majority of stockholders, aims to meet Nasdaq’s requirement...
Moderna to Collaborate With OpenAI to Launch New Generation of Medicines
Moderna to Collaborate With OpenAI to Launch New Generation of Medicines
Apr 24, 2024
11:36 AM EDT, 04/24/2024 (MT Newswires) -- Moderna ( MRNA ) and OpenAI said Wednesday they will continue to collaborate to launch a new generation of medicines. The drugmaker and Microsoft ( MSFT )-backed (MSFT) OpenAI started their collaboration in early 2023 with the launch of Moderna's ( MRNA ) own instance of ChatGPT, called mChat. Moderna ( MRNA )...
Caltech resolves lawsuit against HP over Wi-Fi patents
Caltech resolves lawsuit against HP over Wi-Fi patents
Apr 24, 2024
April 24 (Reuters) - The California Institute of Technology has agreed to drop its lawsuit accusing HP Inc ( HPQ ) of infringing patents related to wireless communications, according to a filing in Texas federal court. Caltech and HP told the U.S. District Court for the Western District of Texas on Tuesday that they would dismiss the case with prejudice,...
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism
Apr 24, 2024
11:33 AM EDT, 04/24/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said Wednesday that the UK's Medicines and Healthcare Products Regulatory Agency has granted marketing authorization for Yorvipath as a parathyroid hormone, or PTH, replacement therapy to treat adults with chronic hypoparathyroidism. The UK regulator also granted orphan drug status to Yorvipath, or palopegteriparatide, providing 10 years of market...
Copyright 2023-2025 - www.financetom.com All Rights Reserved